A novel agonist with homobivalent single-domain antibodies that bind the FGF receptor 1 domain III functions as an FGF2 ligand.
Yonehara R, Kumachi S, Kashiwagi K, Wakabayashi-Nakao K, Motohashi M, Murakami T, Yanagisawa T, Arai H, Murakami A, Ueno Y, Nemoto N, Tsuchiya M.
Yonehara R, et al. Among authors: murakami t, murakami a.
J Biol Chem. 2023 Feb;299(2):102804. doi: 10.1016/j.jbc.2022.102804. Epub 2022 Dec 15.
J Biol Chem. 2023.
PMID: 36529290
Free PMC article.